April 09, 2014
Takeda Pharmaceutical Co. Ltd., Mylan Inc. and others were hit Monday in New York federal court with a proposed antitrust class action by an electrical workers benefit fund that says the companies unlawfully delayed generic competition for diabetes drugs Actos and Actoplus Met.